project id: TCGA-PRAD; case submitter id: TCGA-KK-A6E6; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.56; rna integrity number: 8.3; age at index: 69; days to birth: -25320; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1933; age at diagnosis: 25320; ajcc clinical m: M0; ajcc clinical t: T2b; ajcc pathologic n: N0; ajcc pathologic t: T3a; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 3447.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 4; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 5; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2002; treatment or therapy: no; alcohol history: Not Reported; creation datetime: 1369267200.0; is ffpe: false; portion number: 11; weight: 30.0; composition: Not Reported; days to collection: 3813; days to sample procurement: 0; specimen type: Solid Tissue; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent neutrophil infiltration: 0.0;